glp-1 dementia news Blood Flow to Brain Function: How Therapies May Reduce Risk GLP-1 Microdosing, Brain Health &

In otherwise healthy individuals and/or individuals with obesity who experience sleep disturbances, GLP-1 secretion/activity was found to be attenuated, normal, or even augmented [4452]

In the UK the drugs are only available with permission from a medical doctor, who will issue a prescription only if the patient satisfies the rigorous eligibility criteria

Topline data from their MASH trial is expected this summer, and the alcohol liver disease trial will begin enrolling in the fall

WASHINGTON (TNND) GLP-1 medications have transformed the way doctors treat obesity in adults but as demand grows, a new question is emerging: how young is too young to use these drugs